New study tracks fabry Drug's Real-World impact on heart and kidneys
Disease control
Not yet recruiting
This study follows 75 adults with Fabry disease who are taking or starting pegunigalsidase alfa. Researchers will monitor heart structure, kidney function, and exercise capacity over time to see how well the treatment works in routine medical practice. The goal is to gather real-…
Sponsor: Chiesi Italia • Aim: Disease control
Last updated May 13, 2026 16:03 UTC